223 related articles for article (PubMed ID: 37299413)
1. Post-Marketing Use of Teduglutide in a Large Cohort of Adults with Short Bowel Syndrome-Associated Chronic Intestinal Failure: Evolution and Outcomes.
de Dreuille B; Nuzzo A; Bataille J; Mailhat C; Billiauws L; Le Gall M; Joly F
Nutrients; 2023 May; 15(11):. PubMed ID: 37299413
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of teduglutide treatment for chronic intestinal failure - Insights from a national, multi-centric patient home-care service program.
Greif S; Maasberg S; Wehkamp J; Fusco S; Zopf Y; Herrmann HJ; Lamprecht G; Jacob T; Schiefke I; von Websky MW; Büttner J; Blüthner E; Tacke F; Pape UF
Clin Nutr ESPEN; 2022 Oct; 51():222-230. PubMed ID: 36184208
[TBL] [Abstract][Full Text] [Related]
3. Quality of Life in Teduglutide-Treated Patients with Short Bowel Syndrome Intestinal Failure-A Nested Matched Pair Real-World Study.
Blüthner E; Pape UF; Tacke F; Greif S
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111167
[TBL] [Abstract][Full Text] [Related]
4. Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: A real-world French observational cohort study.
Joly F; Seguy D; Nuzzo A; Chambrier C; Beau P; Poullenot F; Thibault R; Armengol Debeir L; Layec S; Boehm V; Lallemand J; Quilliot D; Schneider SM
Clin Nutr; 2020 Sep; 39(9):2856-2862. PubMed ID: 31932048
[TBL] [Abstract][Full Text] [Related]
5. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.
Jeppesen PB; Pertkiewicz M; Forbes A; Pironi L; Gabe SM; Joly F; Messing B; Loth S; Youssef NN; Heinze H; Berghöfer P
Clin Nutr; 2013 Oct; 32(5):713-21. PubMed ID: 23587733
[TBL] [Abstract][Full Text] [Related]
6. Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure.
Jeppesen PB; Gabe SM; Seidner DL; Lee HM; Olivier C
Gastroenterology; 2018 Mar; 154(4):874-885. PubMed ID: 29174926
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.
Kochar B; Long MD; Shelton E; Young L; Farraye FA; Yajnik V; Herfarth H
J Clin Gastroenterol; 2017 Jul; 51(6):508-511. PubMed ID: 27433811
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Therapy With Teduglutide in Parenteral Support-Dependent Patients With Short Bowel Syndrome: A Case Series.
Ukleja A; To C; Alvarez A; Lara LF
JPEN J Parenter Enteral Nutr; 2018 May; 42(4):821-825. PubMed ID: 29603279
[TBL] [Abstract][Full Text] [Related]
9. Use of teduglutide in adults with short bowel syndrome-associated intestinal failure.
Pironi L; Allard JP; Joly F; Geransar P; Genestin E; Pape UF
Nutr Clin Pract; 2024 Feb; 39(1):141-153. PubMed ID: 37294295
[TBL] [Abstract][Full Text] [Related]
10. Translation of Evidence Into Practice With Teduglutide in the Management of Adults With Intestinal Failure due to Short-Bowel Syndrome: A Review of Recent Literature.
Pironi L
JPEN J Parenter Enteral Nutr; 2020 Aug; 44(6):968-978. PubMed ID: 31802516
[TBL] [Abstract][Full Text] [Related]
11. Short-term clinical evaluation of teduglutide for patients with Crohn's disease on home parenteral support for postoperative short bowel syndrome with intestinal failure.
Sato T; Uchino M; Takeuchi J; Fujihira Y; Shimizu K; Yokoyama K; Yagi S; Kaku K; Takashima Y; Ikenouchi M; Kojima K; Kawai M; Nagase K; Kamikozuru K; Yokoyama Y; Takagawa T; Ikeuchi H; Watanabe K; Shinzaki S
Clin Nutr; 2023 May; 42(5):722-731. PubMed ID: 37001195
[TBL] [Abstract][Full Text] [Related]
12. Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure.
Chen K; Mu F; Xie J; Kelkar SS; Olivier C; Signorovitch J; Jeppesen PB
JPEN J Parenter Enteral Nutr; 2020 Jan; 44(1):119-128. PubMed ID: 31006876
[TBL] [Abstract][Full Text] [Related]
13. Unexpected upper gastrointestinal polyps in patients with short bowel syndrome treated with teduglutide: need for close monitoring.
de Dreuille B; Cazals-Hatem D; Ronot M; Theou-Anton N; Dermine S; Le Beyec-Le Bihan J; Billiauws L; Le Gall M; Bado A; Joly F
Am J Clin Nutr; 2023 Jun; 117(6):1143-1151. PubMed ID: 37270288
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, safety, and pharmacokinetics of teduglutide in adult Japanese patients with short bowel syndrome and intestinal failure: two phase III studies with an extension.
Nakamura S; Wada M; Mizushima T; Sugita A; Tazuke Y; Ohge H; Udagawa E; Suzuki RK; Yoon M; Grimm A; Chen ST; Ikeuchi H
Surg Today; 2023 Mar; 53(3):347-359. PubMed ID: 36201060
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome.
Lambe C; Talbotec C; Kapel N; Barbot-Trystram L; Brabant S; Nader EA; Pigneur B; Payen E; Goulet O
Am J Clin Nutr; 2023 Jun; 117(6):1152-1163. PubMed ID: 37270289
[TBL] [Abstract][Full Text] [Related]
16. Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome.
Iyer KR; Kunecki M; Boullata JI; Fujioka K; Joly F; Gabe S; Pape UF; Schneider SM; Virgili Casas MN; Ziegler TR; Li B; Youssef NN; Jeppesen PB
JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):946-951. PubMed ID: 27875291
[TBL] [Abstract][Full Text] [Related]
17. Imaging as predictor of clinical response to teduglutide in adult patients with short bowel syndrome with chronic intestinal failure.
Martin A; Boehm V; Zappa M; Billiauws L; Bonvalet F; Nuzzo A; Vilgrain V; Joly F; Ronot M
Am J Clin Nutr; 2021 May; 113(5):1343-1350. PubMed ID: 33675349
[TBL] [Abstract][Full Text] [Related]
18. Experience with teduglutide treatment for short bowel syndrome in clinical practice.
Pevny S; Maasberg S; Rieger A; Karber M; Blüthner E; Knappe-Drzikova B; Thurmann D; Büttner J; Weylandt KH; Wiedenmann B; Müller VA; Bläker H; Pascher A; Pape UF
Clin Nutr; 2019 Aug; 38(4):1745-1755. PubMed ID: 30145039
[TBL] [Abstract][Full Text] [Related]
19. Teduglutide improves liver chemistries in short bowel syndrome-associated intestinal failure: Post hoc analysis.
Micic D; Robinson I; Kidd T; Terreri B; Raphael BP
Nutr Clin Pract; 2024 Jun; 39(3):634-640. PubMed ID: 38491966
[TBL] [Abstract][Full Text] [Related]
20. The indications and results of the use of teduglutide in patients with short bowel.
El Khatib M; Billiauws L; Joly F
Curr Opin Clin Nutr Metab Care; 2023 Sep; 26(5):449-454. PubMed ID: 37421385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
